DE60226251D1 - Verbesserung der transfektion von dna in die leber - Google Patents
Verbesserung der transfektion von dna in die leberInfo
- Publication number
- DE60226251D1 DE60226251D1 DE60226251T DE60226251T DE60226251D1 DE 60226251 D1 DE60226251 D1 DE 60226251D1 DE 60226251 T DE60226251 T DE 60226251T DE 60226251 T DE60226251 T DE 60226251T DE 60226251 D1 DE60226251 D1 DE 60226251D1
- Authority
- DE
- Germany
- Prior art keywords
- dna
- transfection
- liver
- improving
- dna encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30378401P | 2001-07-10 | 2001-07-10 | |
US303784P | 2001-07-10 | ||
PCT/US2002/021620 WO2003006608A2 (en) | 2001-07-10 | 2002-07-10 | Enhancement of transfection of dna into the liver |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60226251D1 true DE60226251D1 (de) | 2008-06-05 |
DE60226251T2 DE60226251T2 (de) | 2009-05-14 |
Family
ID=23173680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60226251T Expired - Lifetime DE60226251T2 (de) | 2001-07-10 | 2002-07-10 | Verbesserung der transfektion von dna in die leber |
Country Status (8)
Country | Link |
---|---|
US (2) | US7211248B2 (de) |
EP (1) | EP1420643B1 (de) |
JP (1) | JP4426288B2 (de) |
AT (1) | ATE392812T1 (de) |
AU (1) | AU2002320348B2 (de) |
CA (1) | CA2452471C (de) |
DE (1) | DE60226251T2 (de) |
WO (1) | WO2003006608A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI243696B (en) * | 2003-10-15 | 2005-11-21 | Der-Yang Tien | System for introducing macromolecule substance into living target cell |
US20110071381A1 (en) * | 2003-10-15 | 2011-03-24 | Robert Tien | Method and system for leading macromolecule substances into living target cells |
US8505544B2 (en) * | 2005-05-31 | 2013-08-13 | The Board Of Trustees Of The Leland Stanford Junior University | Optically-implemented microsurgery system and approach |
EP2123256A1 (de) | 2008-05-19 | 2009-11-25 | Ruhr-Universität Bochum | Perfluorkohlenstoff-Nanoemulsionen mit Endozytose-verbessernder Oberfläche für die Genübertragung |
WO2011022672A1 (en) * | 2009-08-20 | 2011-02-24 | Allegheny-Singer Research Institute | Ultrasound-assisted gene transfer to salivary glands |
US9101745B2 (en) * | 2013-03-14 | 2015-08-11 | Sonogene Llc | Sonochemical induction of ABCA1 expression and compositions therefor |
US10052394B2 (en) | 2014-11-21 | 2018-08-21 | General Electric Company | Microbubble tether for diagnostic and therapeutic applications |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8721015D0 (en) * | 1987-09-07 | 1987-10-14 | Amersham Int Plc | Modifying living cells |
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5585112A (en) * | 1989-12-22 | 1996-12-17 | Imarx Pharmaceutical Corp. | Method of preparing gas and gaseous precursor-filled microspheres |
US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
JPH03297475A (ja) * | 1990-04-16 | 1991-12-27 | Ken Ishihara | 共振音波により薬物の放出を制御する方法 |
ATE146073T1 (de) * | 1991-03-22 | 1996-12-15 | Katsuro Tachibana | Verstärker zur ultraschalltherapie von erkrankungen sowie diesen enthaltende flüssige arzneimittelzusammensetzungen |
CN1056124A (zh) | 1991-06-05 | 1991-11-13 | 清华大学 | 高效超声波基因导入方法 |
WO1994010322A1 (en) * | 1992-10-29 | 1994-05-11 | Board Of Regents, The University Of Texas System | Adenovirus-mediated ldl receptor gene transfer and targeting |
DK0693924T4 (da) * | 1993-02-22 | 2008-08-04 | Abraxis Bioscience Inc | Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil |
CA2171303C (en) * | 1993-09-09 | 2006-06-06 | Werner Weitschies | Active principles and gas containing microparticles |
US6048903A (en) * | 1994-05-03 | 2000-04-11 | Robert Toppo | Treatment for blood cholesterol with trans-resveratrol |
US5558092A (en) * | 1995-06-06 | 1996-09-24 | Imarx Pharmaceutical Corp. | Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously |
US6139819A (en) * | 1995-06-07 | 2000-10-31 | Imarx Pharmaceutical Corp. | Targeted contrast agents for diagnostic and therapeutic use |
US6265387B1 (en) * | 1995-10-11 | 2001-07-24 | Mirus, Inc. | Process of delivering naked DNA into a hepatocyte via bile duct |
US20010009904A1 (en) * | 1997-12-30 | 2001-07-26 | Jon A. Wolff | Process of delivering a polynucleotide to a cell via the vascular system |
US5849727A (en) * | 1996-06-28 | 1998-12-15 | Board Of Regents Of The University Of Nebraska | Compositions and methods for altering the biodistribution of biological agents |
DE69738640T2 (de) | 1996-08-15 | 2009-07-16 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Räumliche und temporäre kontrolle der genexpression mittels eines hitzeschockproteinpromotors in kombination mit lokaler hitze |
EP0949932A1 (de) * | 1996-10-19 | 1999-10-20 | Quadrant Healthcare (UK) Limited | Verwendung von mikrokohlkugeln zur diagnose und therapie |
US6120751A (en) * | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
US6416740B1 (en) * | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US6575956B1 (en) | 1997-12-31 | 2003-06-10 | Pharmasonics, Inc. | Methods and apparatus for uniform transcutaneous therapeutic ultrasound |
US6066123A (en) * | 1998-04-09 | 2000-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancement of bioavailability by use of focused energy delivery to a target tissue |
US6135976A (en) * | 1998-09-25 | 2000-10-24 | Ekos Corporation | Method, device and kit for performing gene therapy |
WO2000042988A1 (en) | 1999-01-21 | 2000-07-27 | University Of Virginia | Method of identifying and treating inflamed tissue |
DE60026313D1 (de) * | 1999-07-23 | 2006-04-27 | Uutech Ltd | Sensibilisierung von roten blutkörperchen gegenüber ultraschall durch einwirkung eines elektrischen feldes |
IES990763A2 (en) * | 1999-09-09 | 2001-04-04 | Comtor Ltd | A Wrapping Method and Apparatus |
-
2002
- 2002-07-10 JP JP2003512367A patent/JP4426288B2/ja not_active Expired - Fee Related
- 2002-07-10 CA CA2452471A patent/CA2452471C/en not_active Expired - Fee Related
- 2002-07-10 US US10/483,189 patent/US7211248B2/en not_active Expired - Lifetime
- 2002-07-10 AT AT02749861T patent/ATE392812T1/de not_active IP Right Cessation
- 2002-07-10 AU AU2002320348A patent/AU2002320348B2/en not_active Ceased
- 2002-07-10 DE DE60226251T patent/DE60226251T2/de not_active Expired - Lifetime
- 2002-07-10 WO PCT/US2002/021620 patent/WO2003006608A2/en active IP Right Grant
- 2002-07-10 EP EP02749861A patent/EP1420643B1/de not_active Expired - Lifetime
-
2007
- 2007-04-16 US US11/787,289 patent/US20070196283A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003006608A3 (en) | 2004-03-11 |
WO2003006608A2 (en) | 2003-01-23 |
AU2002320348B2 (en) | 2007-07-19 |
CA2452471C (en) | 2010-06-29 |
CA2452471A1 (en) | 2003-01-23 |
JP2005500327A (ja) | 2005-01-06 |
EP1420643A2 (de) | 2004-05-26 |
AU2002320348B8 (en) | 2003-01-29 |
US20040248832A1 (en) | 2004-12-09 |
ATE392812T1 (de) | 2008-05-15 |
JP4426288B2 (ja) | 2010-03-03 |
US20070196283A1 (en) | 2007-08-23 |
EP1420643B1 (de) | 2008-04-23 |
US7211248B2 (en) | 2007-05-01 |
DE60226251T2 (de) | 2009-05-14 |
EP1420643A4 (de) | 2005-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2132644T3 (es) | Metodo para reproducir in vitro la actividad proteolitica de la proteasa ns3 del virus de la hepatitis c (vhc). | |
ATE234638T1 (de) | Gas-mischungen verwendbar als ultraschallkontrastmittel | |
DE60226251D1 (de) | Verbesserung der transfektion von dna in die leber | |
EA200301278A1 (ru) | Способ получения сложного полиэфира в присутствии диоксида титана с нанесенным покрытием | |
AR038026A1 (es) | Gel que comprende al menos un retinoide y peroxido de benzoilo | |
IT1317951B1 (it) | Leghe getter non evaporabili | |
DE69734605D1 (de) | Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung | |
DE69837393D1 (de) | Stimulierung von hämatopoietischen zellen im vitro | |
HUP0105052A2 (hu) | Eljárások nukleinsav amplifikálására és szekvenálására | |
NO963617L (no) | Gassfylte mikrokapsler til bruk som kontrastmidler | |
DE50016060D1 (de) | Eisenoxid- und Siliciumdioxid-Titandioxid-Mischung | |
ATE492638T1 (de) | Vektorkonstruktionen | |
ATE412755T1 (de) | GENKONSTRUKT DAS FÜR EIN HETEROLOGES ßPRODRUGß- AKTIVIERENDES ENZYM UND FÜR EIN ZELLGERICHTES TEIL KODIERT | |
ATE437951T1 (de) | Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2 | |
DE60108661D1 (de) | Herstellung und verwendung von dendritischen zellen | |
ES2249058T3 (es) | Factores de preservacion de celulas progenitoras y metodos y productos relacionados. | |
DE60137835D1 (de) | Modifizierte zytokine für krebs therapie | |
DE69612993D1 (de) | Verbesserte zusammensetzung mit pseudokatalase | |
FR2866248B1 (fr) | Composition a base d'or et d'un oxyde reductible, procede de preparation et utilisation comme catalyseur, notamment pour l'oxydation du monoxyde de carbone | |
DE69737691D1 (de) | Impfstoff, der peroxiredoxin enthält | |
MXPA03004539A (es) | Luciferasas aisladas y uso de las mismas. | |
DE60030621D1 (de) | DNA-Konstrukt zur gewebespezifischen Expression eines Blutkgerinnungsfaktors | |
MY128030A (en) | Zirconia catalysts supports for nitrous oxide abatement | |
ATE310604T1 (de) | Verwendung eines prozessgasgemisches zum laserstrahlschweissen | |
AR038849A1 (es) | Uso de ribozimas en la deteccion de agentes adventicios |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |